BeiGene Ltd (BGNE)
194.42
+0.16
(+0.08%)
USD |
NASDAQ |
Nov 21, 15:44
BeiGene Price: 194.42 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 195.00 | 198.48 | 192.00 | 194.26 | 261610.0 |
| Nov 19, 2024 | 188.24 | 190.08 | 187.19 | 187.77 | 238525.0 |
| Nov 18, 2024 | 186.92 | 188.32 | 184.49 | 187.69 | 444597.0 |
| Nov 15, 2024 | 187.79 | 191.45 | 186.16 | 189.23 | 273933.0 |
| Nov 14, 2024 | 193.58 | 195.64 | 191.26 | 193.29 | 213477.0 |
| Nov 13, 2024 | 197.44 | 200.88 | 193.28 | 195.45 | 281526.0 |
| Nov 12, 2024 | 198.00 | 203.00 | 189.60 | 193.64 | 335253.0 |
| Nov 11, 2024 | 206.37 | 209.29 | 204.40 | 205.04 | 334489.0 |
| Nov 08, 2024 | 203.84 | 206.35 | 202.59 | 205.47 | 207402.0 |
| Nov 07, 2024 | 202.73 | 208.06 | 202.73 | 206.82 | 144300.0 |
| Nov 06, 2024 | 208.03 | 208.03 | 196.15 | 202.73 | 551774.0 |
| Nov 05, 2024 | 208.13 | 209.99 | 205.62 | 208.03 | 322583.0 |
| Nov 04, 2024 | 204.86 | 210.52 | 204.86 | 207.25 | 177228.0 |
| Nov 01, 2024 | 206.63 | 209.05 | 202.90 | 204.21 | 463006.0 |
| Oct 31, 2024 | 205.50 | 205.99 | 202.19 | 202.64 | 216786.0 |
| Oct 30, 2024 | 213.88 | 213.88 | 205.32 | 205.99 | 898445.0 |
| Oct 29, 2024 | 217.00 | 219.57 | 214.80 | 216.53 | 229354.0 |
| Oct 28, 2024 | 215.11 | 219.03 | 214.30 | 217.22 | 142696.0 |
| Oct 25, 2024 | 213.18 | 215.26 | 211.30 | 212.81 | 245775.0 |
| Oct 24, 2024 | 214.75 | 221.60 | 213.62 | 214.15 | 157964.0 |
| Oct 23, 2024 | 223.88 | 224.00 | 218.82 | 221.01 | 145157.0 |
| Oct 22, 2024 | 219.14 | 221.12 | 218.45 | 220.63 | 107826.0 |
| Oct 21, 2024 | 220.00 | 221.84 | 217.31 | 219.92 | 187949.0 |
| Oct 18, 2024 | 222.35 | 222.35 | 215.12 | 218.97 | 528238.0 |
| Oct 17, 2024 | 219.40 | 220.66 | 211.56 | 212.39 | 397094.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
121.11
Minimum
May 11 2022
403.14
Maximum
Sep 17 2021
221.43
Average
200.21
Median
Jun 16 2023
Price Benchmarks
| Theravance Biopharma Inc | 9.64 |
| Merck & Co Inc | 100.01 |
| Bristol-Myers Squibb Co | 58.16 |
| Zai Lab Ltd | 25.79 |
| Halozyme Therapeutics Inc | 45.40 |
Price Related Metrics
| PS Ratio | 6.139 |
| Price to Book Value | 6.033 |
| Earnings Yield | -4.28% |
| Market Cap | 20.73B |